Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 86098

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
June 18, 2020
Product types
Device
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Chembio Diagnostics, Inc

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 3

Chembio DPP COVID-19 IgM/IgG System- Rrapid immunochromatographic test for the qualitative detection and differentiation of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to SARS-CoV-2 in fingerstick whole blood, venous whole blood, serum, or plasma (lithium heparin or EDTA. Model Number: 65-9569-0

Z-2807-2020
Recall number
Z-2807-2020
Initiated
June 18, 2020
Classification
Class II
Status
Terminated
Recalling firm
Chembio Diagnostics, Inc
Quantity
7,674 kits (153,480 devices)

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
FDA revocation of the Emergency Use Authorization due to performance issues

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Device Design

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

FDA revocation of the Emergency Use Authorization due to performance issues

Code information

Lot Numbers: CV041020/A CV041520 CV040220/A1 CV042420 CV042920 CV040320/A2 CV050120

Distribution pattern

Nationwide

device · product 2 of 3

Chembio DPP¿ Micro Reader for use with the DPP¿ COVID-19 IgM/IgG System- Rapid immunochromatographic test for the qualitative detection and differentiation of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to SARS-CoV-2 in fingerstick whole blood, venous whole blood, serum, or plasma (lithium heparin or EDTA. Model Number: 70-1069-0

Z-2808-2020
Recall number
Z-2808-2020
Initiated
June 18, 2020
Classification
Class II
Status
Terminated
Recalling firm
Chembio Diagnostics, Inc
Quantity
126 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
FDA revocation of the Emergency Use Authorization due to performance issues

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Device Design

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

FDA revocation of the Emergency Use Authorization due to performance issues

Code information

Lot Numbers: 83716171 83720151 83720153

Distribution pattern

Nationwide

device · product 3 of 3

Chembio DPP¿ Micro Reader II for use with the DPP¿ COVID-19 IgM/IgG System- Rapid immunochromatographic test for the qualitative detection and differentiation of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to SARS-CoV-2 in fingerstick whole blood, venous whole blood, serum, or plasma (lithium heparin or EDTA. Model Number: 70-1070-0

Z-2809-2020
Recall number
Z-2809-2020
Initiated
June 18, 2020
Classification
Class II
Status
Terminated
Recalling firm
Chembio Diagnostics, Inc
Quantity
97 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
FDA revocation of the Emergency Use Authorization due to performance issues

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Device Design

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

FDA revocation of the Emergency Use Authorization due to performance issues

Code information

Lot Numbers: 96820051 96820052 96820181 96820191 96820201

Distribution pattern

Nationwide